About the Countdown to a Cure for AIDS

amfAR’s Countdown to a Cure for AIDS is a research initiative aimed at developing the scientific basis for a cure by 2020. Launched in February 2014, the Countdown is designed to intensify amfAR’s cure-focused HIV research program through strategic investments of $100 million over the next five years. 

There has never been a more optimistic time in the world of HIV/AIDS research.  The case of the Berlin Patient, first reported in 2008, was a watershed moment and a proof of principle that a cure was possible. This and other breakthroughs over the last several years have brought the scientific community a new understanding of the challenges that must be overcome to get to a cure. And there is growing confidence that, with the right investments, these challenges can be overcome. 

This momentum, coupled with the availability of new and emerging technologies, has led us to believe that now is the time to mount an all-out effort to find a cure that will herald the beginning of the end of HIV/AIDS.

In just the first 24 months of amfAR’s Countdown to a Cure for AIDS initiative, we have supported 139 principal investigators and key personnel in 16 U.S. states and 9 other countries around the world.

 

This represents the greatest expansion of research grant-making in amfAR’s 30-year history.
— Kevin Robert Frost, amfAR Chief Executive Officer

Explore more about Countdown to a Cure